Once you put the EHR, lab data, alerts, and an integrated communication system into the hands of your clinicians – on one application, the next step is providing real-time clinical decision-making tools in the very same way.
While antibiotics save lives, according to the CDC, poor prescribing practices are putting patients at risk for preventable allergic reactions, super-resistant infections, and deadly diarrhea. With more than half of all hospital patients receiving at least one antibiotic, the potential for errors is high. These errors also contribute to antibiotic resistance.
We recently partnered with ILÚM Health Solutions, a wholly-owned subsidiary of Merck’s Healthcare Services and Solutions division, to expedite delivery of infectious disease alerts to clinicians. We are excited to combine our strength in delivering real-time clinical information to the care team’s secure mobile devices with ILÚM’s ability to rapidly extract and synthesize critical data from the pharmacy and lab. Our integration will enable PatientTouch hospitals to improve their ability to adhere to the established clinical pathways for antimicrobial stewardship (AMS) and sepsis, leading to better infectious disease outcomes.
The ILÚM technology analyzes patient data in accordance with institution-specific guidelines and highlights high-risk patients and intervention opportunities, decreasing the cognitive load on the care team. Notifications from ILÚM are routed in real-time to the assigned caregiver or on-call AMS team, enabling immediate triage and rapid coordination between the care team and pharmacy for medication changes – all-in-one smartphone application.
This is just one step on this road to increasingly more sophisticated predictive analytics. Between sepsis, falls and anti-microbial stewardship alerts, we feel our app capabilities will not only help hospitals improve outcomes, but it will also significantly reduce the cost of errors and sentinel situations – especially with hospital-acquired infectious disease.
We are extremely pleased to support clinicians with these capabilities because with the volume and velocity of information they must handle to effectively manage patients with infectious diseases, this kind of synthesized results and insights, are extremely valuable.